SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-04-003023
Filing Date
2004-01-12
Accepted
2004-01-12 08:39:35
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-3/A ds3a.htm S-3/A 335386
3 CONSENT OF ERNST & YOUNG LLP dex231.htm EX-23.1 1673
4 CONSENT OF ERNST & YOUNG LLP dex232.htm EX-23.2 1788
5 CONSENT OF ROPES & GRAY LLP dex233.htm EX-23.3 1764
6 GRAPHIC g84887g24r93.jpg GRAPHIC 23094
  Complete submission text file 0001193125-04-003023.txt   365728
Mailing Address 100 BEAVER STREET WALTHAM MA 02453
Business Address 1OO BEAVER ST WALTHAM MA 02453 7813982300
GENOME THERAPEUTICS CORP (Filer) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 0831
Type: S-3/A | Act: 33 | File No.: 333-111273 | Film No.: 04519535
SIC: 2835 In Vitro & In Vivo Diagnostic Substances